LZCIC(600423)
Search documents
柳化股份:柳化股份关于召开2023年第二次临时股东大会的通知
2023-10-27 10:21
证券代码:600423 证券简称:柳化股份 公告编号:2023-022 柳州化工股份有限公司 关于召开 2023 年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一) 股东大会类型和届次 2023 年第二次临时股东大会 召开的日期时间:2023 年 11 月 15 日 14 点 30 分 召开地点:广西柳州市跃进路 106-8 号汇金国际 26 层公司会议室 1 股东大会召开日期:2023年11月15日 本次股东大会采用的网络投票系统:上海证券交易所股东大会网络投票 系统 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票,应按照《上海证券交易所上市公司自律监管指引第 1 号 — 规范运 作》等有关规定执行。 (七) 涉及公开征集股东投票权 无 二、 会议审议事项 本次股东大会审议议案及投票股东类型 | 序 | 议案名称 | 投票股东类型 | | --- | --- | ...
柳化股份:柳化股份关于对相关债权及资产进行核销的公告
2023-10-27 10:21
股票代码:600423 股票简称:柳化股份 公告编号:2023-021 柳州化工股份有限公司 关于对相关债权及资产进行核销的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 柳州化工股份有限公司(以下简称"公司")于 2023 年 10 月 27 日召开第六届董事会第十四次会议 及第六届监事会第九次会议审议通过了三项关于对相关债权及资产进行核销的议案。现将相关情况公告 如下: 1、关于对司法重整账面记载未申报债权进行核销账务处理的事项 2019 年 12 月 13 日,公司收到柳州中院(2018)桂 02 破 2 号之八《民事裁定书》,裁定确认公 司重整计划执行完毕并终结公司重整程序,截至目前公司司法重整计划执行完毕已满三年。根据公司《重 整计划》中"自重整计划执行完毕之日起三年内,账面记载未申报债权之债权人主张债权且经审查依法 成立的,按照上述同类债权的清偿条件受偿。超过三年未主张或虽主张但经审查不成立的,不再清偿" 的约定,公司拟对《重整计划》执行完毕公告之日起满三年仍未向公司主张的债权共计 4507.76 万元进 行 ...
柳化股份:柳化股份关于召开2023年半年度业绩说明会的公告
2023-08-10 09:48
股票代码:600423 股票简称:柳化股份 公告编号:2023-017 重要内容提示: ●会议召开时间:2023 年 8 月 18 日(星期五) 15:00-16:00 ●问题征集方式:投资者可于 2023 年 8 月 11 日(星期五)至 8 月 17 日(星期四)16:00 前登录上证路演中 心网站首页点击"提问预征集"栏目或通过公司邮箱 lhgf@vip.163.com 进行提问。公司将在说明会上对投资 者普遍关心的问题进行回答。 柳州化工股份有限公司(以下简称"公司")已于 2023 年 7 月 28 日在《上海证券报》及上海证券交易所 网站(www.sse.com.cn)披露了公司 2023 年半年度报告及其摘要,为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况,公司计划于 2023 年 8 月 18 日 15:00-16:00 召开 2023 年半年度业绩说明 会,就投资者关心的问题进行交流。 一、 说明会类型 本次业绩说明会以网络互动形式召开,公司将针对 2023 年半年度的经营成果及财务指标的具体情况与投 资者进行互动交流和沟通,在信息披露允许的范围内就投资者普遍关心 ...
柳化股份(600423) - 2023 Q2 - 季度财报
2023-07-27 16:00
Financial Performance - The company's operating revenue for the first half of 2023 was ¥56,266,043.18, a decrease of 14.95% compared to ¥66,157,909.10 in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2023 was ¥2,232,306.66, down 78.98% from ¥10,622,208.43 in the previous year[19]. - The basic earnings per share for the first half of 2023 was ¥0.003, a decrease of 76.92% from ¥0.013 in the same period last year[21]. - The weighted average return on net assets decreased by 1.97 percentage points to 0.51% from 2.48% in the previous year[21]. - The operating profit for the first half of 2023 was ¥2,232,306.66, down from ¥10,592,228.06 in the first half of 2022, indicating a significant decline in profitability[89]. - The net profit for the first half of 2023 was also ¥2,232,306.66, compared to ¥10,622,208.43 in the same period of 2022, reflecting a decrease of approximately 79%[89]. Cash Flow and Assets - The net cash flow from operating activities increased by 75.88% to ¥16,934,868.95, compared to ¥9,628,771.61 in the same period last year[22]. - Cash and cash equivalents at the end of the period reached ¥418,755,795.07, accounting for 80.58% of total assets, an increase of 2.49% compared to the previous year[39]. - The total assets at the end of the reporting period were ¥519,708,496.80, an increase of 1.28% from ¥513,141,913.12 at the end of the previous year[20]. - The company's total non-current assets reached ¥73,818,273.10, an increase from ¥57,914,985.73 at the end of 2022, indicating a growth of approximately 27.4%[85]. - The company's cash and cash equivalents were ¥418,755,795.07 as of June 30, 2023, compared to ¥408,580,137.82 at the end of 2022, showing a slight increase[84]. Market Conditions and Challenges - The company faced significant challenges due to oversupply in the hydrogen peroxide industry, leading to a substantial decrease in profitability[21]. - The overall market for hydrogen peroxide remains weak, with an expected continuation of low prices due to excess supply and insufficient demand[29]. - The overall market competition for hydrogen peroxide has intensified due to increased production capacity and low downstream demand[28]. Production and Technical Upgrades - The company completed a technical upgrade of its 20,000 tons/year concentrated hydrogen peroxide production system, significantly reducing steam consumption and improving market competitiveness[32]. - The company plans to expand its hydrogen peroxide production capacity by 60,000 tons/year through technical upgrades[31]. - The company is undertaking a technical upgrade project for its 100,000 tons/year hydrogen peroxide facility, with a total investment of approximately ¥22,870,000, expected to enhance production capacity from 100,000 tons to 160,000 tons annually[42]. Environmental Impact and Compliance - The company’s Luozhai subsidiary has been included in the 2023 Liuzhou Environmental Supervision Key Units List, with major pollutants including wastewater, waste gas, and hazardous waste[52]. - Total emissions during the reporting period were 0.0937 tons of volatile organic compounds, 0.000042 tons of ammonia nitrogen, and 0.0043 tons of chemical oxygen demand[52]. - The subsidiary achieved a 100% operational rate for environmental protection facilities in sync with production equipment, ensuring real-time monitoring of emissions[54]. - The company has implemented energy-saving measures, optimizing hydrogen peroxide production processes and eliminating high-energy-consuming equipment, contributing to effective greenhouse gas emission control[60]. - There were no instances of exceeding emission standards during the reporting period[53]. Shareholder Information - As of the end of the reporting period, the total number of ordinary shareholders was 20,645[74]. - The largest shareholder, LiuZhou YuanTong Investment Development Co., Ltd., holds 201,452,434 shares, representing 25.22% of the total shares[76]. - The second largest shareholder, China Construction Bank, holds 49,256,529 shares, accounting for 6.17%[76]. Related Party Transactions - The company expects to engage in related party transactions amounting to approximately 41 million RMB for the purchase of hydrogen and steam, with actual transactions recorded at 15.8 million RMB[68]. - The company sold 0.4 million RMB worth of hydrogen peroxide to a related party, with actual sales amounting to 98.73 thousand RMB[68]. Financial Stability and Governance - The company operates on a continuous basis with no significant doubts regarding its ability to continue operations for the next 12 months[106]. - The financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance[107]. - The company has not reported any changes in significant accounting policies or estimates for the current period[173]. Inventory and Receivables Management - Inventory rose by 43.33% to ¥7,094,407.76, mainly due to an increase in spare parts and product stock[39]. - The total accounts receivable at the end of the period amounted to CNY 3,591,088.24, with a bad debt provision of CNY 525,345.47, resulting in a net value of CNY 3,065,742.77[182]. - The provision for bad debts increased from CNY 456,447.90 to CNY 525,345.47 during the reporting period[186].
柳化股份(600423) - 2023 Q1 - 季度财报
2023-04-18 16:00
[Important Notes](index=1&type=section&id=Important%20Notes) This section provides essential declarations from the board and management, along with the audit status of the financial statements [Declaration by Board of Directors, Supervisory Board, and Senior Management](index=1&type=section&id=Declaration%20by%20Board%20of%20Directors%2C%20Supervisory%20Board%2C%20and%20Senior%20Management) The company's board, supervisory board, and senior management declare the quarterly report's content to be true, accurate, and complete, assuming legal responsibility - The company's board of directors, supervisory board, and directors, supervisors, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, free from false records, misleading statements, or major omissions, and assume individual and joint legal responsibility[3](index=3&type=chunk) [Audit Status of Financial Statements](index=1&type=section&id=Audit%20Status%20of%20Financial%20Statements) The financial statements for the first quarter of this reporting period are unaudited - The financial statements for the first quarter are unaudited[3](index=3&type=chunk) [Key Financial Data](index=1&type=section&id=Key%20Financial%20Data) This section presents the company's primary accounting data, financial indicators, non-recurring gains and losses, and explanations for significant changes [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1 2023, operating revenue decreased by 11.31% year-over-year, and net profit attributable to shareholders decreased by 39.39%, while net cash flow from operating activities increased by 91.81%; total assets at period-end grew by 2.53% from year-end Key Accounting Data and Financial Indicators | Item | Current Reporting Period (Yuan) | Year-over-year Change (%) | | :--- | :--- | :--- | | Operating Revenue | 29,435,798.46 | -11.31 | | Net Profit Attributable to Shareholders of Listed Company | 2,020,023.05 | -39.39 | | Net Cash Flow from Operating Activities | 12,357,605.36 | 91.81 | | Basic Earnings Per Share (Yuan/share) | 0.003 | -25.00 | | Weighted Average Return on Net Assets (%) | 0.46 | Decrease 0.33 percentage points | Key Balance Sheet Data | Item | End of Current Reporting Period (Yuan) | End of Previous Year (Yuan) | Change from Previous Year-end (%) | | :--- | :--- | :--- | :--- | | Total Assets | 526,121,797.03 | 513,141,913.12 | 2.53 | | Total Equity Attributable to Shareholders of Listed Company | 438,240,440.15 | 436,830,628.08 | 0.32 | [Non-Recurring Gains and Losses and Amounts](index=2&type=section&id=Non-Recurring%20Gains%20and%20Losses%20and%20Amounts) Total non-recurring gains and losses for this period amounted to 2,641.38 Yuan, primarily from government subsidies recognized in current profit or loss Non-Recurring Gains and Losses | Item | Current Period Amount (Yuan) | | :--- | :--- | | Government subsidies recognized in current profit or loss | 2,641.38 | | Total | 2,641.38 | [Changes and Reasons for Key Accounting Data and Financial Indicators](index=2&type=section&id=Changes%20and%20Reasons%20for%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Several balance sheet items, including accounts receivable, prepayments, and construction in progress, significantly increased due to higher credit sales, advance payments for purchases/expenses, and technical renovation investments; the decline in profit was mainly due to the sluggish hydrogen peroxide market, which reduced selling prices and compressed profit margins; increased operating cash inflow primarily resulted from the settlement of maturing bank acceptance bills Changes and Reasons for Key Accounting Data and Financial Indicators | Item | Change (%) | Primary Reason | | :--- | :--- | :--- | | Accounts Receivable | 57.86 | Primarily due to increased credit sales in the current period | | Prepayments | 2,033.38 | Primarily due to increased advance payments for purchases | | Other Receivables | 845.56 | Primarily due to increased advance payments for expenses | | Construction in Progress | 206.67 | Primarily due to investment in related technical renovation projects | | Other Non-current Assets | 433.68 | Primarily due to increased advance payments for long-term asset acquisitions | | Contract Liabilities | 225.96 | Primarily due to increased advance receipts from customers for goods | | Operating Profit | -39.39 | Primarily due to the sluggish 27.5% hydrogen peroxide market in the current period, leading to a decrease in selling prices compared to the same period last year, which compressed profit margins | | Net Cash Flow from Operating Activities | 91.81 | Primarily due to an increase in maturing bank acceptance bills settled in the current period compared to the same period last year | [Shareholder Information](index=3&type=section&id=Shareholder%20Information) This section details the total number of common shareholders, preferred shareholders with restored voting rights, and the top ten shareholders' holdings [Total Number of Common Shareholders, Preferred Shareholders with Restored Voting Rights, and Top Ten Shareholders' Holdings](index=3&type=section&id=Total%20Number%20of%20Common%20Shareholders%2C%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%2C%20and%20Top%20Ten%20Shareholders%27%20Holdings) As of the end of the reporting period, the company had 20,857 common shareholders, with state-owned legal entities dominating the top ten, and Liuzhou Yuantong Investment Development Co., Ltd. as the largest shareholder with a 25.22% stake; some state-owned legal entity shareholders have related party or concerted action relationships - Total number of common shareholders at the end of the reporting period was **20,857**[9](index=9&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Nature | Number of Shares Held (shares) | Shareholding Percentage (%) | Share Status | Quantity (shares) | | :--- | :--- | :--- | :--- | :--- | :--- | | Liuzhou Yuantong Investment Development Co., Ltd. | State-owned Legal Entity | 201,452,434 | 25.22 | None | 0 | | China Construction Bank Corporation Guangxi Branch | State-owned Legal Entity | 49,256,529 | 6.17 | Unknown | 0 | | Liuzhou Chemical Industry Group Co., Ltd. | State-owned Legal Entity | 22,826,167 | 2.86 | Pledged | 17,260,000 | | | | | | Frozen | 22,826,167 | - Liuzhou Yuantong Investment Development Co., Ltd. is a wholly-owned subsidiary of Liuzhou State-owned Assets Supervision and Administration Commission and acts in concert with Liuhua Group; China Construction Bank Corporation Guangxi Branch acts in concert with CCB Financial Leasing Co., Ltd[10](index=10&type=chunk) [Other Reminders](index=4&type=section&id=Other%20Reminders) This section addresses any other significant information regarding the company's operating performance during the reporting period that investors should note [Other Important Information Regarding the Company's Operating Performance During the Reporting Period That Investors Should Note](index=4&type=section&id=Other%20Important%20Information%20Regarding%20the%20Company%27s%20Operating%20Performance%20During%20the%20Reporting%20Period%20That%20Investors%20Should%20Note) There is no other important information regarding the company's operating performance during the reporting period that requires special attention from investors - No other important information regarding the company's operating performance during the reporting period requires investor attention[11](index=11&type=chunk) [Quarterly Financial Statements](index=5&type=section&id=Quarterly%20Financial%20Statements) This section presents the company's unaudited quarterly financial statements, including the balance sheet, income statement, and cash flow statement [Type of Audit Opinion](index=5&type=section&id=Type%20of%20Audit%20Opinion) The financial statements for this quarter are unaudited - The financial statements for this quarter are unaudited[12](index=12&type=chunk) [Financial Statements](index=5&type=section&id=Financial%20Statements) This section includes the company's unaudited balance sheet, income statement, and cash flow statement, reflecting its financial position, operating results, and cash flows for Q1 2023 [Balance Sheet](index=5&type=section&id=Balance%20Sheet) As of March 31, 2023, total assets were **526.12 million Yuan**, a 2.53% increase from year-end, with monetary funds being the largest current asset and fixed assets/construction in progress as major non-current assets; total liabilities were **87.88 million Yuan**, and total owner's equity was **438.24 million Yuan** Balance Sheet | Item | March 31, 2023 (Yuan) | December 31, 2022 (Yuan) | | :--- | :--- | :--- | | Monetary Funds | 416,729,471.84 | 408,580,137.82 | | Accounts Receivable | 2,826,744.47 | 1,790,698.53 | | Prepayments | 3,168,143.66 | 148,503.41 | | Construction in Progress | 3,516,124.52 | 1,146,560.73 | | Total Assets | 526,121,797.03 | 513,141,913.12 | | Total Liabilities | 87,881,356.88 | 76,311,285.04 | | Total Owner's Equity | 438,240,440.15 | 436,830,628.08 | [Income Statement](index=7&type=section&id=Income%20Statement) In Q1 2023, the company achieved operating revenue of **29.44 million Yuan**, a 11.31% year-over-year decrease, with operating costs of **28.80 million Yuan**, and net profit of **2.02 million Yuan**, a 39.39% year-over-year decrease, primarily due to the sluggish hydrogen peroxide market Income Statement | Item | Q1 2023 (Yuan) | Q1 2022 (Yuan) | | :--- | :--- | :--- | | Operating Revenue | 29,435,798.46 | 33,189,922.46 | | Operating Cost | 28,795,082.21 | 30,989,546.43 | | Operating Profit | 2,020,023.05 | 3,332,803.57 | | Net Profit | 2,020,023.05 | 3,332,803.57 | | Basic Earnings Per Share (Yuan/share) | 0.003 | 0.004 | [Cash Flow Statement](index=8&type=section&id=Cash%20Flow%20Statement) In Q1 2023, net cash flow from operating activities was **12.36 million Yuan**, a significant 91.81% year-over-year increase, mainly due to increased cash received from sales; net cash outflow from investing activities was **4.25 million Yuan**, primarily for acquiring fixed, intangible, and other long-term assets; period-end cash and cash equivalents totaled **388.59 million Yuan** Cash Flow Statement | Item | Q1 2023 (Yuan) | Q1 2022 (Yuan) | | :--- | :--- | :--- | | Cash received from sales of goods and rendering of services | 26,925,587.87 | 17,448,333.68 | | Net Cash Flow from Operating Activities | 12,357,605.36 | 6,442,575.77 | | Cash paid for acquisition of fixed assets, intangible assets, and other long-term assets | 4,251,462.18 | 723,557.10 | | Net Cash Flow from Investing Activities | -4,251,462.18 | -723,557.10 | | Net Increase in Cash and Cash Equivalents | 8,106,143.18 | 5,719,018.67 | | Cash and Cash Equivalents at End of Period | 388,587,214.99 | 368,027,745.00 | [Adjustments to Financial Statements at the Beginning of the First Year of Application of New Accounting Standards or Interpretations from 2023](index=10&type=section&id=Adjustments%20to%20Financial%20Statements%20at%20the%20Beginning%20of%20the%20First%20Year%20of%20Application%20of%20New%20Accounting%20Standards%20or%20Interpretations%20from%202023) The company did not adjust its opening financial statements for the current reporting period due to the initial application of new accounting standards or interpretations - No adjustments were made to the opening financial statements for the current reporting period due to the initial application of new accounting standards or interpretations[19](index=19&type=chunk)
柳化股份:柳化股份关于召开2022年度业绩说明会的公告
2023-03-22 08:04
股票代码:600423 股票简称:柳化股份 公告编号:2023-012 柳州化工股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ●会议召开时间:2023 年 3 月 30 日(星期四)上午 10:00-11:00 ●会议召开地点:上海证券交易所上证路演中心(网址:http://roadshow.sseinfo.com/) ●会议召开方式:上证路演中心网络文字互动 ●问题征集方式:投资者可于 2023 年 3 月 23 日(星期四)至 3 月 29 日(星期三)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 lhgf@vip.163.com 进行提问。 公司将在说明会上对投资者普遍关心的问题进行回答。 (一) 会议召开时间:2023 年 3 月 30 日上午 10:00-11:00 (二) 会议召开地点:上海证券交易所上证路演中心(http://roadshow.sseinfo.com/) (三) 会议召开方式:上证路演中心网络 ...
柳化股份(600423) - 2022 Q4 - 年度财报
2023-03-15 16:00
Financial Performance - In 2022, the company's operating revenue was approximately CNY 140.46 million, an increase of 10.35% compared to CNY 127.29 million in 2021[24] - The net profit attributable to shareholders was CNY 15.86 million, a decrease of 44.97% from CNY 28.81 million in the previous year[24] - The net cash flow from operating activities increased significantly to CNY 24.45 million, representing a 303.72% increase from CNY 6.06 million in 2021[26] - The total assets at the end of 2022 were CNY 513.14 million, up 5.77% from CNY 485.16 million at the end of 2021[24] - The net assets attributable to shareholders increased to CNY 436.83 million, a rise of 3.39% compared to CNY 422.52 million in 2021[24] - Basic earnings per share decreased by 50% to CNY 0.02 from CNY 0.04 in the previous year[25] - The weighted average return on equity decreased to 3.68%, down 3.39 percentage points from 7.07% in 2021[25] - The company plans not to distribute profits for 2022 due to a negative cumulative undistributed profit of CNY -217.24 million[6] Production and Sales - The company produced over 120,000 tons of hydrogen peroxide in 2022, achieving a production capacity utilization rate exceeding 100%[33] - The production volume of 27.5% hydrogen peroxide was 122,672 tons, a year-on-year increase of 20.30%, while sales volume was 124,410 tons, up 24.07%[51] - The average price of hydrogen peroxide in Sichuan reached approximately CNY 1,300 per ton, while in Shandong it was below CNY 800 per ton[40] - The company did not produce 50% hydrogen peroxide during the reporting period, resulting in a 100% decrease in production volume[52] - The company's sales volume of 27.5% hydrogen peroxide reached 124,400 tons, achieving a regional market share of 14.30%[71] Costs and Expenses - The gross margin for 27.5% hydrogen peroxide decreased by 5.61 percentage points due to a 34.74% increase in production costs[49] - Sales expenses increased by 39.39% primarily due to higher weighing and travel costs[45] - Direct materials accounted for ¥72,457,706.00, which is 85.35% of total costs, up from 81.04% last year, reflecting a 21.54% increase[54] - The cost of direct materials for 27.5% hydrogen peroxide increased by 32.46% year-on-year, primarily due to a 20.30% increase in production volume and rising raw material prices[54] Market Environment - The chemical industry saw a 19% increase in investment in 2022, indicating a positive trend in the sector's growth[38] - The average price index for the chemical manufacturing industry increased by 7.7% year-on-year in 2022, with 60% of key products experiencing price growth[38] - The overall average price and operating rate of hydrogen peroxide in the domestic market decreased compared to the previous year, indicating a challenging market environment[68] Legal and Compliance Issues - The company faced significant legal liabilities which impacted net profit and earnings metrics[25] - The company has received a court ruling confirming a bankruptcy claim of approximately ¥25.89 million, which has been accounted for in the current period's losses[35] - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties[8] Corporate Governance - The company held its annual general meeting on March 30, 2022, where nine proposals, including the 2021 annual report and profit distribution plan, were approved[96] - The first extraordinary general meeting of 2022 was held on September 21, 2022, where a proposal for the addition of supervisors was approved[96] - The company has maintained a consistent shareholding structure with no changes in the number of shares held by directors and supervisors during the reporting period[98] - The company has implemented a performance assessment method for determining the remuneration of its directors and senior management, based on various regulatory guidelines[107] Environmental Responsibility - The company has established a mechanism for environmental protection, with an investment of CNY 365,300 in environmental protection funds during the reporting period[146] - The company has implemented a soil pollution prevention plan and completed a soil pollution risk assessment report in 2022[150] - The company has developed a self-monitoring plan for emissions and solid waste management, complying with national standards[152] Future Plans and Strategies - The company plans to upgrade its production capacity for 27.5% hydrogen peroxide from 100,000 tons to 160,000 tons annually, enhancing its market risk resilience[34] - The company plans to invest in a technical upgrade project to expand hydrogen peroxide production capacity by 60,000 tons/year, expected to be completed by September 2023[76] - The company aims to implement "three zeros" in safety: zero major safety accidents, zero major equipment accidents, and zero major pollution incidents in 2023[84] - The company is actively expanding into the new energy market to mitigate the adverse effects of declining prices in traditional markets[33] Audit and Financial Reporting - The audit report confirmed that the financial statements fairly reflect the company's financial position and operating results for the year ended December 31, 2022[189] - The audit procedures included verifying bank account balances, checking sales contracts, and analyzing revenue recognition practices to ensure compliance with accounting standards[195][197] - Management is responsible for ensuring the financial statements are prepared in accordance with accounting standards and for maintaining effective internal controls[200]
柳化股份(600423) - 2022 Q3 - 季度财报
2022-10-28 16:00
2022 年第三季度报告 证券代码:600423 证券简称:柳化股份 柳州化工股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中 财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期比 上年同期增 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 减变动幅度 | 年初至报告期末 | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 39,368,606.12 | 29.07 | 105,526,515.22 | 16.80 | | 归属 ...
柳化股份(600423) - 2022 Q2 - 季度财报
2022-07-28 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was CNY 66,157,909.10, representing a 10.54% increase compared to CNY 59,849,259.86 in the same period last year[15]. - The net profit attributable to shareholders decreased by 50.14% to CNY 10,622,208.43 from CNY 21,303,089.90 year-on-year[15]. - The basic earnings per share decreased by 51.85% to CNY 0.013 from CNY 0.027 in the previous year[15]. - Operating profit for the first half of 2022 was CNY 10,592,228.06, down 49.1% from CNY 20,804,773.77 in the first half of 2021[73]. - Net profit for the first half of 2022 was CNY 10,622,208.43, a decrease of 50.1% compared to CNY 21,303,089.90 in the first half of 2021[73]. Cash Flow and Liquidity - The net cash flow from operating activities fell by 58.56% to CNY 9,628,771.61, primarily due to a significant reduction in cash received from sales[16][17]. - The company faced a cash flow challenge, with net cash flow from operating activities dropping by 58.56% to CNY 9,628,771.61[27]. - The company's cash flow from operating activities for the first half of 2022 was CNY 9,628,771.61, down 58.6% from CNY 23,234,814.72 in the first half of 2021[76]. - The company has a frozen account balance of ¥25,889,840.00 at the Construction Bank, which may impact liquidity[168]. Production and Sales - The company's production of 27.5% hydrogen peroxide increased by 14.90% year-on-year to 58,252 tons, while sales volume rose by 21.73% to 57,878 tons[25]. - The average selling price of 27.5% hydrogen peroxide decreased by 9.43% year-on-year to CNY 1,008.83 per ton, leading to a revenue increase of only 10.54% to CNY 66,157,909.10[25][27]. - The company's net profit fell by 50.14% year-on-year to CNY 1,062,220.00 due to rising production costs and declining product prices[25]. - Operating costs surged by 43.21% year-on-year to CNY 58,089,133.87, primarily driven by increased prices of electricity and raw materials[27]. Assets and Liabilities - The company's total assets increased by 2.16% to CNY 495,645,347.97 from CNY 485,161,409.73 at the end of the previous year[16]. - The net assets attributable to shareholders rose by 2.49% to CNY 433,040,968.91 from CNY 422,518,809.47 at the end of the previous year[16]. - Total liabilities remained stable at CNY 62,604,379.06 compared to CNY 62,642,600.26 in the previous period[71]. - The total owner's equity at the end of the period was 414,837,891.74 RMB, reflecting a decrease from 422,518,809.47 RMB at the end of the previous period[82]. Market Conditions and Risks - The decline in profitability was attributed to rising costs of electricity and raw materials, coupled with weak downstream demand for hydrogen peroxide, leading to compressed profit margins[15][17]. - The market for hydrogen peroxide remains weak, with an expected oversupply in the second half of the year due to additional production capacity coming online[23]. - The company is facing risks related to market price fluctuations and high raw material costs, which could further impact profitability[34]. Legal and Regulatory Issues - A court has frozen CNY 25,889,800.00 of the company's bank deposits due to a lawsuit regarding contract breach[32]. - The company faced a lawsuit from Fujian Sanneng Energy Technology Co., Ltd. involving a principal amount of CNY 25.8898 million, with the court ruling against the company in the first instance[53]. - The company is currently involved in another lawsuit with Shanxi Huaxin Blue Ocean Industry Co., Ltd. regarding a contract dispute, with a principal amount of CNY 66.0422 million, which is still under trial[53]. Environmental and Sustainability Practices - The company has established a 100% operational rate for its environmental protection facilities, ensuring compliance with pollution discharge standards[47]. - The company promotes green practices among employees, such as paperless offices and energy-saving lighting, to contribute to sustainable development[48]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[46]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period was 22,568[62]. - The top shareholder, Liuzhou Yuantong Investment Development Co., Ltd., holds 201,452,434 shares, representing 25.22% of the total shares[64]. - The total number of shares held by the top ten shareholders includes significant stakes from state-owned enterprises, indicating a strong institutional presence[65]. Accounting Policies and Financial Reporting - The financial statements reflect the company's financial position as of June 30, 2022, and the operating results and cash flows for the first half of 2022[93]. - The accounting policies comply with the requirements of the "Enterprise Accounting Standards" and provide a true and complete reflection of the company's financial status[93]. - The company includes all subsidiaries in its consolidated financial statements, ensuring comprehensive financial reporting[99].
柳化股份(600423) - 2022 Q1 - 季度财报
2022-04-29 16:00
Financial Performance - The company's operating revenue for Q1 2022 was CNY 33,189,922.46, representing a year-on-year increase of 14.73%[6] - The net profit attributable to shareholders decreased by 71.53% to CNY 3,332,803.57 compared to the same period last year[6] - The basic earnings per share decreased by 73.33% to CNY 0.004[6] - The company's net profit for Q1 2022 was CNY 3,332,803.57, a decrease from CNY 11,708,148.33 in Q1 2021, representing a decline of approximately 71.5%[19] - The total comprehensive income for Q1 2022 was CNY 3,332,803.57, significantly lower than CNY 11,708,148.33 in Q1 2021, indicating a decrease of around 71.5%[19] - The company reported operating income of CNY 3,332,803.57 for Q1 2022, down from CNY 11,630,515.39 in Q1 2021, a decline of approximately 71.4%[19] Cash Flow - The net cash flow from operating activities was CNY 6,442,575.77, down 32.74% year-on-year[6] - Cash flow from operating activities for Q1 2022 was CNY 6,442,575.77, compared to CNY 9,578,191.00 in Q1 2021, reflecting a decrease of approximately 32.5%[21] - Cash inflow from operating activities totaled CNY 20,973,733.29 in Q1 2022, compared to CNY 34,299,504.04 in Q1 2021, a decline of approximately 38.7%[21] - Cash outflow from operating activities was CNY 14,531,157.52 in Q1 2022, down from CNY 24,721,313.04 in Q1 2021, reflecting a decrease of about 41.2%[21] - The net increase in cash and cash equivalents for Q1 2022 was CNY 5,719,018.67, compared to CNY 9,578,191.00 in Q1 2021, indicating a decrease of approximately 40.5%[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 490,905,545.92, an increase of 1.18% from the end of the previous year[7] - The company's total assets as of March 31, 2022, were CNY 490,905,545.92, an increase from CNY 485,161,409.73 as of December 31, 2021[14] - The total current liabilities as of March 31, 2022, were CNY 65,096,102.25, compared to CNY 62,642,600.26 at the end of 2021[15] - The company had cash and cash equivalents of CNY 396,231,043.50 as of March 31, 2022, slightly up from CNY 390,465,948.65 at the end of 2021[14] Operational Metrics - Accounts receivable increased by 2,390.79%, primarily due to an increase in product sales on credit[9] - Inventory increased by 308.48%, mainly due to an increase in raw material stock for production[9] - Operating costs rose by 67.92%, attributed to a significant increase in sales volume and rising prices of energy and raw materials[9] - Sales expenses increased by 70.36%, mainly due to higher sales-related costs and weighing expenses[9] - The company experienced a decline in gross profit margin due to lower market prices for hydrogen peroxide and increased production costs[9] - The company reported a significant increase in management expenses, which rose to CNY 2,241,731.65 in Q1 2022 from CNY 1,885,304.98 in Q1 2021[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 23,468[11] - The largest shareholder, LiuZhou YuanTong Investment Development Co., Ltd., holds 201,452,434 shares, accounting for 25.22% of the total shares[11] Product and Technology Development - The company has not disclosed any new product or technology developments in the current reporting period[13]